ursolic acid has been researched along with Malignant Melanoma in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul-Al, A; Abildgaard, C; Christensen, A; Christiansen, H; Dahl, C; Filomeni, G; Guldberg, P; Rizza, S; Schmidt, S | 1 |
| Bojin, F; Caunii, A; Cristea, M; Drăghia, L; Ivan, A; Oprean, C; Paunescu, V; Soica, C; Tatu, C | 1 |
| Avram, S; Caunii, A; Cristea, M; Danciu, C; Dehelean, C; Ivan, A; Marti, D; Oprean, C; Paunescu, V; Soica, C; Spandidos, DA; Susan, R; Tatu, C; Tsatsakis, A; Tzanakakis, G | 1 |
| Alvarado, HL; Calpena, AC; Clares, B; Garduño-Ramírez, ML; Melguizo, C; Ortiz, R; Prados, JC | 1 |
| Du, R; Liu, P; Yu, X | 1 |
| Glickman, RD; Kumar, N; Lee, YH; Wang, E | 1 |
| Borcan, F; Coricovac, D; Crăiniceanu, Z; Danciu, C; Dehelean, CA; Munteanu, M; Oprean, C; Soica, C; Trandafirescu, C | 1 |
| Balali-Mood, M; Karimi, G; Mahmoudi, M; Rabe, SZ; Riahi-Zanjani, B; Tabasi, N | 1 |
| Badran, B; Fidanzi-Dugas, C; Hassan, L; Liagre, B; Limami, Y; Martin, F; Pinon, A; Seeman, J; Simon, A | 1 |
| Cook-Moreau, J; Delage, C; Duval, RE; Harmand, PO; Jayat-Vignoles, C; Pinon, A; Simon, A | 1 |
10 other study(ies) available for ursolic acid and Malignant Melanoma
| Article | Year |
|---|---|
Screening of metabolic modulators identifies new strategies to target metabolic reprogramming in melanoma.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Discovery; Glycolysis; Humans; Hymecromone; Melanoma; Mitochondria; Oxidants; Oxidative Stress; Protein Kinase Inhibitors; Small Molecule Libraries; Triterpenes; Ursolic Acid | 2021 |
Selective in vitro anti-melanoma activity of ursolic and oleanolic acids.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Melanoma; Mesenchymal Stem Cells; Oleanolic Acid; Triterpenes; Ursolic Acid | 2018 |
Effects of ursolic and oleanolic on SK‑MEL‑2 melanoma cells: In vitro and in vivo assays.
Topics: Angiogenesis Inhibitors; Animals; Cell Adhesion; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Humans; Melanoma; Neovascularization, Physiologic; Oleanolic Acid; Skin Neoplasms; Triterpenes; Ursolic Acid | 2017 |
Nanoemulsion Strategy for Ursolic and Oleanic Acids Isolates from
Topics: Animals; Antioxidants; Apocynaceae; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Emulsions; Melanoma; Mice; Molecular Conformation; Nanoparticles; Oleanolic Acid; Structure-Activity Relationship; Triterpenes; Ursolic Acid | 2018 |
Ursolic Acid Exhibits Potent Anticancer Effects in Human Metastatic Melanoma Cancer Cells (SK-MEL-24) via Apoptosis Induction, Inhibition of Cell Migration and Invasion, Cell Cycle Arrest, and Inhibition of Mitogen-Activated Protein Kinase (MAPK)/ERK Sign
Topics: Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Humans; MAP Kinase Signaling System; Melanoma; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Proto-Oncogene Proteins c-bcl-2; Triterpenes; Ursolic Acid | 2019 |
Ursolic acid differentially modulates apoptosis in skin melanoma and retinal pigment epithelial cells exposed to UV-VIS broadband radiation.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Cell Cycle Checkpoints; Cell Line; Cell Proliferation; Humans; Light; Melanoma; Melanoma, Cutaneous Malignant; Mitochondria; Reactive Oxygen Species; Retinal Pigment Epithelium; Sirolimus; Skin Neoplasms; Transcription Factor RelA; Triterpenes; Tumor Suppressor Protein p53; Ultraviolet Rays; Ursolic Acid | 2014 |
The synergistic biologic activity of oleanolic and ursolic acids in complex with hydroxypropyl-γ-cyclodextrin.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Cell Line, Tumor; Cell Survival; Drug Carriers; Drug Synergism; Female; gamma-Cyclodextrins; Humans; Melanoma; Mice; Oleanolic Acid; Skin Neoplasms; Solubility; Triterpenes; Ultraviolet Rays; Ursolic Acid | 2014 |
Ursolic acid induced apoptotic cell death following activation of caspases in isolated human melanoma cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Proliferation; G1 Phase Cell Cycle Checkpoints; Humans; Melanoma; Triterpenes; Ursolic Acid | 2015 |
Resistance to ursolic acid-induced apoptosis through involvement of melanogenesis and COX-2/PGE2 pathways in human M4Beu melanoma cancer cells.
Topics: Apoptosis; Aspirin; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Dinoprostone; Drug Resistance, Neoplasm; Humans; MAP Kinase Signaling System; Melanins; Melanoma; Proto-Oncogene Proteins c-akt; Signal Transduction; Triterpenes; Up-Regulation; Ursolic Acid | 2016 |
Differential involvement of mitochondria during ursolic acid-induced apoptotic process in HaCaT and M4Beu cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Caspase 3; Caspase 9; Cell Line, Tumor; Flow Cytometry; Humans; Keratinocytes; Melanoma; Membrane Potential, Mitochondrial; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Triterpenes; Ursolic Acid | 2008 |